Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  BUDAPEST STOCK EXCHANGE  >  Richter Gedeon Vegyeszeti Gyar Nyrt    GDRB   HU0000123096

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( HUF)
Sales 2017 435 B
EBIT 2017 62 318 M
Net income 2017 55 859 M
Finance 2017 83 627 M
Yield 2017 1,45%
Sales 2018 466 B
EBIT 2018 73 027 M
Net income 2018 72 468 M
Finance 2018 120 B
Yield 2018 1,91%
P/E ratio 2017 21,41
P/E ratio 2018 16,91
EV / Sales2017 2,61x
EV / Sales2018 2,36x
Capitalization 1 220 B
More Financials
Company
The Chemical Works of Gedeon Richter Plc develops and manufactures pharmaceuticals.It operates through the following segments: Pharmaceuticals, Wholesale and Retail, and Others.The Pharmaceutical segment comprises of the research and development, manufacture, retail and marketing of pharmaceutical... 
Sector
Pharmaceuticals
Calendar
11/08Earnings Release
More about the company
Surperformance© ratings of Richter Gedeon Vegyeszeti
Trading Rating : Investor Rating :
More Ratings
Latest news on RICHTER GEDEON VEGYESZETI
10/12 RICHTER GEDEON VEGYESZETI GYAR : signed a licensing agreement with Pharmanest to..
10/02 RICHTER GEDEON VEGYESZETI GYAR : Extraordinary announcement
07/19 RICHTER GEDEON VEGYESZETI GYAR : European Commission approved Reagila® (caripraz..
06/01 RICHTER GEDEON VEGYESZETI GYAR NYRT : ex-dividend day for annual dividend
05/19 RICHTER GEDEON VEGYESZETI GYAR : European CHMP Issues Positive Opinion for Carip..
05/12 RICHTER GEDEON VEGYESZETI GYAR : Payment of dividends by Chemical Works of Gedeo..
01/19 RICHTER GEDEON VEGYESZETI GYAR : signed a distribution and supply agreement with..
01/17 RICHTER GEDEON VEGYESZETI GYAR : Allergan and Richter Announce Positive Phase II..
2016 RICHTER GEDEON VEGYESZETI GYAR : withdraws marketing application for biosimilar ..
2016 RICHTER GEDEON VEGYESZETI GYAR : announces withdrawal of its marketing authorisa..
More news
Sector news : Generic Pharmaceuticals
10/21 JOHNSON & JOHNSON : California judge tosses $417 million talc cancer verdict aga..
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
More sector news : Generic Pharmaceuticals
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 7 189  HUF
Spread / Average Target 9,8%
EPS Revisions
Managers
NameTitle
Erik Bogsch Chairman & Chief Executive Officer
Attila Chikán Chairman-Supervisory Board
Gábor Gulácsi Chief Financial Officer & Director
Istvan Greiner Director-Research
William Henry Marie de Gelsey Director